Info on the data files and the aelq R script accompanying the paper: Vinh-Hung V, Gorobets O, Adriaenssens N, Van Parijs H, Storme G, Verellen D, Nguyen NP, Magne N, De Ridder M. Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients. Cancers. 2022; 14(24):6241. https://doi.org/10.3390/cancers14246241 "aelq2_base2.txt" = baseline characteristics. "aelq3.txt" = longitudinal maesurements. Variables in "aelq2_base2.txt": "aelq2_base2.txt" = baseline characteristics. # Age at randomization, years. # RTdose: cf TomoBreast papers. # 51 Gy = hypofractionated, simultaneous integrated boost # 42 Gy = hypofractionated, no boost, mastectomy cases only # 50 Gy = conventional, no boost, mastectomy cases only # 66 Gy = conventional, sequential boost # Weight kg, Height cm, # Detection 1=found by screening (senology follow-up/controle) # 2=found by symptoms (pain, palpable) # 9=unknown # Smoker 0= Not smoker # 1= Smoker # 2=ex-smoker # Mastectomy (and other binary coded) 1= yes # chemosched 0=none # 1= planned after RT (sequential) # 2= prior to RT and is finished (sequential) # 3= chemo is on-going or is planned to start with RT (concomitant) # hormonetherapy 0=no # 1=tamoxifen (nolvadex) # 2=Femara (Letrozole) # 3=zoladex # 4=tamoxifen + zoladex # Laterality 1,=Right, 2=Left, 3=Bilateral # LengthFU: length of follow-up, days from randomization "aelq3.txt" = longitudinal maesurements. # "Nr" = Case ID # "Time" in days from origin (origin =date of randomization), # if negative =before randomization # "KPS" "Weight" # "Died" "LocalRec" "Metast" "NewPrim" = binary code, 0=no, 1=yes # "fAEBreast" "fAEHeart" "fAELung" "fAEOther" # fAE = freedom from breast, heart, lung, other adverse event score # "LVEF2" = ejection fraction, % # "MacIver" = estimated cardiac strain # the following are pulmonary function tests, untransformed units # "FVC", "FEV1", "PEF", "VC", "TLC", "RV", "FRC", "Raw", "sRaw", "DLCO", # "VA", "PF" # "fDY", "fFA", "fPA" = freedom from dyspnea, from fatigue, from pain # range 0 to 100 (best) # see paper: # Van Parijs, H.; Vinh-Hung, V.; Fontaine, C.; Storme, G.; Verschraegen, C.; # Nguyen, D.M.; Adriaenssens, N.; Nguyen, N.P.; Gorobets, O.; De Ridder, M. # Cardiopulmonary-related patient-reported outcomes in a randomized clinical # trial of radiation therapy for breast cancer. BMC Cancer 2021, 21, 1177, # doi:10.1186/s12885-021-08916-z. # # "Year" = year of the observation # example: randomized 1/1/2011, measurement done 1/31/2011, time = 30 days, # Year =2011 #